South San Francisco, CA, United States of America

Junhua Wang

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Denali Therapeutics Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junhua Wang. Retrieved from https://idiyas.com/inventor/junhua-wang-h2ahxggb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Junhua Wang - Innovator in Biopharmaceuticals

Introduction

Junhua Wang is a notable inventor based in South San Francisco, CA (US). He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative research and development efforts.

Latest Patents

Wang holds a patent titled "Anti-Transferrin Receptor Fusion Proteins and Methods of Use Thereof." This patent reflects his expertise in creating novel therapeutic proteins that have the potential to advance treatment options in various medical conditions. He has 1 patent to his name, showcasing his commitment to innovation in the industry.

Career Highlights

Currently, Junhua Wang is employed at Denali Therapeutics Inc., a company dedicated to developing therapies for neurodegenerative diseases. His work at Denali Therapeutics highlights his role in advancing scientific research and improving patient outcomes through innovative solutions.

Collaborations

Wang collaborates with talented professionals in his field, including colleagues Annie Arguello and Tina Giese. These collaborations enhance the research environment and foster the development of groundbreaking therapies.

Conclusion

Junhua Wang's contributions to the field of biopharmaceuticals exemplify the impact of innovation on healthcare. His work continues to inspire advancements that may lead to improved treatments for patients in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…